Upstream Bio, Inc. (UPB) Reports Q1 Loss, Beats Revenue Estimates
13/5 14:20
Upstream Bio, Inc. (UPB) delivered earnings and revenue surprises of +5.96% and +102.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...